| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ADC Therapeutics SA | Director | Common Shares | 108,286 | $387,663 | $3.58 | 13 Jun 2025 | Direct |
| Merus N.V. | Director | Share Option (right to buy) | 0 | $119,571 | $13.52 | 12 Dec 2025 | Direct |
| Prelude Therapeutics Inc | Director | Director Stock Option (Right to Buy) | 121,285 | 05 Nov 2025 | Direct | ||
| Kymera Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 16,000 | 25 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MRUS | Merus N.V. | 12 Dec 2025 | 7 | $0 | 4 | Director | 12 Dec 2025, 18:54 |
| PRLD | Prelude Therapeutics Inc | 05 Nov 2025 | 1 | $0 | 4 | Director | 07 Nov 2025, 16:28 |
| KYMR | Kymera Therapeutics, Inc. | 25 Jun 2025 | 1 | $0 | 4 | Director | 26 Jun 2025, 21:00 |
| ADCT | ADC Therapeutics SA | 13 Jun 2025 | 1 | -$45,108 | 4 | Director | 17 Jun 2025, 17:03 |
| PRLD | Prelude Therapeutics Inc | 12 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 16:15 |
| ADCT | ADC Therapeutics SA | 03 Jun 2025 | 1 | $0 | 4 | Director | 05 Jun 2025, 17:12 |
| MRUS | Merus N.V. | 22 May 2025 | 1 | $0 | 4 | Director | 27 May 2025, 08:00 |
| KYMR | Kymera Therapeutics, Inc. | 18 Jun 2024 | 1 | $0 | 4 | Director | 20 Jun 2024, 17:00 |
| ADCT | ADC Therapeutics SA | 17 Jun 2024 | 1 | -$20,216 | 4 | Director | 18 Jun 2024, 21:37 |
| PRLD | Prelude Therapeutics Inc | 14 Jun 2024 | 1 | $0 | 4 | Director | 18 Jun 2024, 16:14 |
| ADCT | ADC Therapeutics SA | 13 Jun 2024 | 1 | $0 | 4 | Director | 14 Jun 2024, 17:29 |
| MRUS | Merus N.V. | 07 May 2024 | 1 | $0 | 4 | Director | 09 May 2024, 16:30 |
| ADCT | ADC Therapeutics SA | 02 Jan 2024 | 0 | $0 | 3 | Director | 02 Jan 2024, 20:01 |
| PRLD | Prelude Therapeutics Inc | 16 Jun 2023 | 1 | $0 | 4 | Director | 21 Jun 2023, 16:16 |
| KYMR | Kymera Therapeutics, Inc. | 15 Jun 2023 | 1 | $0 | 4 | Director | 20 Jun 2023, 16:16 |
| MRUS | Merus N.V. | 08 Jun 2023 | 1 | $0 | 4 | Director | 12 Jun 2023, 16:13 |
| KYMR | Kymera Therapeutics, Inc. | 03 Nov 2022 | 1 | $0 | 4 | Director | 03 Nov 2022, 19:22 |
| KYMR | Kymera Therapeutics, Inc. | 03 Nov 2022 | 0 | $0 | 3 | Director | 03 Nov 2022, 19:19 |
| PRLD | Prelude Therapeutics Inc | 17 Jun 2022 | 1 | $0 | 4 | Director | 22 Jun 2022, 16:14 |
| MRUS | Merus N.V. | 31 May 2022 | 1 | $0 | 4 | Director | 02 Jun 2022, 16:05 |
| PRLD | Prelude Therapeutics Inc | 03 Jan 2022 | 1 | $0 | 4 | Director | 05 Jan 2022, 16:11 |
| PRLD | Prelude Therapeutics Inc | 13 Oct 2021 | 1 | $0 | 4 | Director | 14 Oct 2021, 18:56 |
| PRLD | Prelude Therapeutics Inc | 18 Jun 2021 | 1 | $0 | 4 | Director | 22 Jun 2021, 17:42 |
| MRUS | Merus N.V. | 28 May 2021 | 1 | $0 | 4 | Director | 02 Jun 2021, 16:10 |